Showing results (901-910 of 9,976) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|December 7, 2016
Outcome of pediatric advanced Hodgkin lymphoma treated with ABVD and predictors of inferior survival: a multicenter study of 186 patientsSainath Bhethanabhotla, Sandeep Jain, Gauri Kapoor, et al.Leukemia & Lymphoma|December 7, 2016
Current trends in molecular diagnostics of chronic myeloid leukemiaRaquel Vinhas, Milton Cordeiro, Pedro Pedrosa, et al.Leukemia & Lymphoma|May 6, 2014
Phase I trial of SAR103168, a novel multi-kinase inhibitor, in patients with refractory/relapsed acute leukemia or high-risk myelodysplastic syndromeGail J Roboz, H Jean Khoury, Elias Jabbour, et al.Leukemia & Lymphoma|May 6, 2014
Granulocyte-colony stimulating factor response is superior to neutropenia duration in predicting the risk of infection after high-dose chemotherapy for myeloma and lymphomaChristian Straka, Hans Salwender, Brigitte Schnabel, et al.Leukemia & Lymphoma|December 10, 2016
Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003-2013Mary Gleeson, Eliza A Hawkes, Clare Peckitt, et al.Leukemia & Lymphoma|December 10, 2016
Modulation of leukotriene signaling inhibiting cell growth in chronic myeloid leukemiaElham Yektaei-Karin, Ana Zovko, Anders Nilsson, et al.Leukemia & Lymphoma|October 21, 2016
Modeling the chronic lymphocytic leukemia microenvironment in vitroKyle Crassini, Yandong Shen, Stephen Mulligan, et al.Leukemia & Lymphoma|October 21, 2016
The prognostic value of bone marrow involvement at the molecular level in aggressive lymphomaNeta Goldschmidt, Fares Darawshy, Geffen Kleinstern, et al.Leukemia & Lymphoma|November 5, 2016
Is there a role for a maintenance rituximab in indolent lymphoproliferative diseases other than follicular lymphoma?Alden A Moccia, Emanuele Zucca, Michele GhielminiLeukemia & Lymphoma|November 5, 2016
Targeting histone deacetylases in T-cell lymphomaAlison J Moskowitz, Steven M HorwitzPageof 998